360 related articles for article (PubMed ID: 17877447)
1. Paclitaxel: a review of adverse toxicities and novel delivery strategies.
Marupudi NI; Han JE; Li KW; Renard VM; Tyler BM; Brem H
Expert Opin Drug Saf; 2007 Sep; 6(5):609-21. PubMed ID: 17877447
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel in head and neck and other cancers: future prospects.
Aisner J; Cortés-Funes H
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-113-S2-115. PubMed ID: 9045328
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
Rowinsky EK; Chaudhry V; Forastiere AA; Sartorius SE; Ettinger DS; Grochow LB; Lubejko BG; Cornblath DR; Donehower RC
J Clin Oncol; 1993 Oct; 11(10):2010-20. PubMed ID: 7692001
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study.
Hurwitz CA; Relling MV; Weitman SD; Ravindranath Y; Vietti TJ; Strother DR; Ragab AH; Pratt CB
J Clin Oncol; 1993 Dec; 11(12):2324-9. PubMed ID: 7902425
[TBL] [Abstract][Full Text] [Related]
5. [Paclitaxel (Taxol)].
Hájek R
Cas Lek Cesk; 1996 Jun; 135(12):393-6. PubMed ID: 8706079
[TBL] [Abstract][Full Text] [Related]
6. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].
Yamazaki S; Sekine I; Saijo N
Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372
[TBL] [Abstract][Full Text] [Related]
7. Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer.
Eniu A; Palmieri FM; Perez EA
Oncologist; 2005 Oct; 10(9):665-85. PubMed ID: 16249346
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.
Tolcher AW
Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
Natale RB
Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
11. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
Johnson DH; Paul DM; Hande KR; DeVore R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel by 3-hour infusion followed by 96-hour infusion on failure in patients with refractory malignant disease.
Chang AY; Boros L; Garrow G; Asbury R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):124-7. PubMed ID: 7597429
[TBL] [Abstract][Full Text] [Related]
15. nab-paclitaxel: a novel formulation of taxane for treatment of breast cancer.
Vishnu P; Roy V
Womens Health (Lond); 2010 Jul; 6(4):495-506. PubMed ID: 20597612
[TBL] [Abstract][Full Text] [Related]
16. Response to estramustine phosphate and paclitaxel in patients with advanced breast cancer: a phase I study.
Keren-Rosenberg S; Muggia FM
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S26-9. PubMed ID: 9071337
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience.
Sledge GW; Robert N; Sparano JA; Cobeligh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W
Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756
[TBL] [Abstract][Full Text] [Related]
19. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents.
Rowinsky EK
Annu Rev Med; 1997; 48():353-74. PubMed ID: 9046968
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
